Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 43 pharmaceuticals ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 13:20 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- First
- Royalty Pharma65.6%
- Median
- 12.5%
- Combined market value
- HUF 1731.56T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | HUF 13.26T | HUF 23,055.19 | 0.23% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | HUF 1.69T | HUF 20,262.25 | 1.00% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | HUF 8.35T | HUF 196,076.53 | 0.64% down | 23% up | ||
| 4 | Novo NordiskNVO · Health Care | 41.3% | HUF 60.22T | HUF 13,662.58 | 2.16% down | 17% down | ||
| 5 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | HUF 45.47T | HUF 179,325.60 | 0.67% down | 27% up | ||
| 6 | NovartisNVS · Health Care | 32.4% | HUF 100.89T | HUF 53,418.35 | 0.67% down | 25% up | ||
| 7 | GenmabGMAB · Health Care | 28.6% | HUF 10.75T | HUF 17,442.45 | 0.76% up | 70% up | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | HUF 33.26T | HUF 321,510.45 | 0.56% up | 36% up | ||
| 9 | AbbVieABBV · Health Care | 24.6% | HUF 173.75T | HUF 98,296.75 | 0.59% down | 26% up | ||
| 10 | GSKGSK · Health Care | 24.3% | HUF 33.13T | HUF 16,529.38 | 2.32% down | 6% up | ||
| 11 | AstraZenecaAZN · Health Care | 23.4% | HUF 94.89T | HUF 61,186.22 | 0.95% down | 2% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 20.0% | HUF 3.18T | HUF 21,051.12 | 0.08% down | 107% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | 18.2% | HUF 60.88T | HUF 35,150.10 | 2.55% down | 17% down | ||
| 14 | AlkermesALKS · Health Care | 17.2% | HUF 2.56T | HUF 15,257.11 | 2.32% down | 58% up | ||
| 15 | GrifolsGRFS · Health Care | 16.5% | HUF 1.97T | HUF 2,897.00 | 1.15% down | 1% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | HUF 1.97T | HUF 98,629.08 | 2.62% down | 43% up | ||
| 17 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | HUF 4.14T | HUF 4,964.86 | 0.61% up | 5% up | ||
| 18 | SanofiSNY · Health Care | 14.5% | HUF 38.31T | HUF 15,955.35 | 1.78% down | 4% down | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | HUF 7.04T | HUF 52,535.49 | 2.02% down | 66% down | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | HUF 2.47T | HUF 7,089.77 | 0.52% down | 83% up | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | HUF 3.8T | HUF 19,641.22 | 0.90% up | 11% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | HUF 16.69T | HUF 14,307.11 | 0.12% up | 74% up | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | HUF 2.04T | HUF 14,431.31 | 2.76% down | 10% up | ||
| 24 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | HUF 2.51T | HUF 31,927.48 | 0.93% up | 126% up | ||
| 25 | BeOne MedicinesONC · Health Care | 8.37% | HUF 15.85T | HUF 138,727.25 | 0.48% up | 17% up | ||
| 26 | Corcept TherapeuticsCORT · Health Care | 5.88% | HUF 2.57T | HUF 23,521.80 | 1.23% up | 8% down | ||
| 27 | Takeda PharmaceuticalTAK · Health Care | 0.14% | HUF 23.21T | HUF 7,264.33 | 0.23% up | 54% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | HUF 2.02T | HUF 30,866.70 | 0.40% up | 31% up | ||
| 29 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | HUF 5.19T | HUF 80,803.94 | 0.39% up | 37% up | ||
| 30 | Travere TherapeuticsTVTX · Health Care | -12.8% | HUF 1.65T | HUF 17,153.76 | 2.82% up | 44% up | ||
| 31 | Legend BiotechLEGN · Health Care | -13.3% | HUF 1.05T | HUF 5,407.97 | 0.75% up | 42% down | ||
| 32 | ViatrisVTRS · Health Care | -18.6% | HUF 7.87T | HUF 6,864.86 | 1.40% down | 96% up | ||
| 33 | Ascendis PharmaASND · Health Care | -18.9% | HUF 5.97T | HUF 91,035.77 | 0.20% down | 28% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | -26.1% | HUF 2.4T | HUF 45,637.06 | 0.77% down | 7% down | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | HUF 3.29T | HUF 141,657.82 | 0.46% down | 24% down | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | HUF 1.51T | HUF 9,050.20 | 3.75% down | 64% down | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | HUF 2.71T | HUF 39,144.81 | 8.49% up | 13% up | ||
| 38 | BridgeBio PharmaBBIO · Health Care | -104% | HUF 5.02T | HUF 25,780.99 | 0.72% down | 17% up | ||
| 39 | InsmedINSM · Health Care | -206% | HUF 8.97T | HUF 40,907.18 | 0.83% down | 40% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | -344% | HUF 2.73T | HUF 41,850.47 | 0.13% down | 46% up | ||
| 41 | CytokineticsCYTK · Health Care | -695% | HUF 2.42T | HUF 17,338.39 | 2.86% down | 20% down | ||
| 42 | Roivant SciencesROIV · Health Care | -6236% | HUF 9.42T | HUF 12,994.56 | 0.26% up | 90% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | -8739% | HUF 1.64T | HUF 29,198.32 | 2.87% down | 113% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 335.7 HUF). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 43 pharmaceuticals ranked by operating margin as of 18 Nov 2026, 13:20 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of HUF 1731.56T as of 18 Nov 2026, 13:20 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.